Although the underlying molecular mechanisms are still not completely clear, anti-melanoma differentiation-associated gene 5 (MDA5)-positive dermatomyositis (MDA5+ DM) is reported to be associated with rapidly progressive ILD (RP-ILD), resulting in high mortality rates. Here, IFIH1 is linked to dermatomyositis.